CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer’s Disease
暂无分享,去创建一个
Huadong Zhou | Yanjiang Wang | F. Zeng | Yu-Hui Liu | Zeyan Peng | Shuyang Dong | Ling Li | Huiyun Li
[1] S. Stumpf,et al. Cholesterol in myelin biogenesis and hypomyelinating disorders. , 2015, Biochimica et biophysica acta.
[2] Huadong Zhou,et al. CYP46A1 T/C polymorphism associated with the APOEε4 allele increases the risk of Alzheimer’s disease , 2013, Journal of Neurology.
[3] Huaxi Xu,et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.
[4] Zhenxin Zhang,et al. An Intronic CYP46A1 Polymorphism Is Associated with Alzheimer Disease in a Chinese Han Population , 2012, Journal of Molecular Neuroscience.
[5] C. Dotti,et al. Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons , 2011, Neurobiology of Aging.
[6] M. Grimaldi,et al. Interaction of a β‐sheet breaker peptide with lipid membranes , 2010, Journal of peptide science : an official publication of the European Peptide Society.
[7] R. Martins,et al. Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease , 2009, Journal of neurochemistry.
[8] Ariadna Besga,et al. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease , 2009, Neuroscience Letters.
[9] Anália Nusya Medeiros Garcia,et al. Cyp46 Polymorphisms in Alzheimer’s Disease: A Review , 2009, Journal of Molecular Neuroscience.
[10] F. Jessen,et al. CYP46A1 variants influence Alzheimer’s disease risk and brain cholesterol metabolism , 2009, European Psychiatry.
[11] G. Vitiello,et al. Interaction between Alzheimer's Abeta(25-35) peptide and phospholipid bilayers: the role of cholesterol. , 2008, Biochimica et biophysica acta.
[12] J. Jia,et al. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese , 2007, Brain Research.
[13] B. Cheung,et al. Intron 2 (T/C) CYP46 Polymorphism Is Associated with Alzheimer’s Disease in Chinese Patients , 2006, Dementia and Geriatric Cognitive Disorders.
[14] S. Sorbi,et al. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease , 2006, Neurobiology of Aging.
[15] H. Chiu,et al. Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population , 2006, International Psychogeriatrics.
[16] H. Soininen,et al. Association of CYP46 intron 2 polymorphism in Finnish Alzheimer’s disease samples and a global scale summary , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[17] F. LaFerla,et al. Alzheimer's disease: Aβ, tau and synaptic dysfunction , 2005 .
[18] C. Caltagirone,et al. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators , 2004, Neurobiology of Aging.
[19] K. Fassbender,et al. Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide , 2002, Neurology.
[20] P. S. St George-Hyslop. Genetic Factors in the Genesis of Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.
[21] H Jick,et al. Statins and the risk of dementia , 2000, The Lancet.
[22] G. Celesia,et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.
[23] F. Jessen,et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. , 2000, Journal of lipid research.
[24] J M Guileyardo,et al. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Wahren,et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. , 1998, Journal of lipid research.
[26] D. Lütjohann,et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. M. Saunders,et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.
[28] Stephen W. Scheff,et al. Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.
[29] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[30] A. Chobanian,et al. Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol. , 1962, The Journal of clinical investigation.
[31] L. Bertram. Alzheimer's disease genetics: Current status and future perspectives , 2009, Alzheimer's & Dementia.
[32] L. Bertram. Alzheimer's disease genetics current status and future perspectives. , 2009, International review of neurobiology.
[33] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[34] Frank M LaFerla,et al. Alzheimer's disease: Abeta, tau and synaptic dysfunction. , 2005, Trends in molecular medicine.
[35] H. Braak,et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. , 2003, Archives of neurology.
[36] F. Licastro,et al. Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits. , 2002, Journal of Alzheimer's disease : JAD.
[37] F. Jessen,et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. , 2002, Journal of psychiatric research.
[38] M A Pericak-Vance,et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.